HomeInsights52 Week Low Stocks

Suven Pharmaceuticals Ltd 52 Week Low

Suven Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 2.0 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

19.0 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Suven Pharmaceuticals Ltd

NSE: SUVENPHAR

YEARLOW

₹ 586.1

Last updated on: Jan 15, 2025

Key Highlights

  • The 52 Week Low of Suven Pharmaceuticals Ltd is ₹ 586.1 as of 15 Jan 25 .

Company Fundamentals for Suven Pharmaceuticals Ltd

No data available

Market Price of Suven Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251055.15
14 Jan 20251054.75
13 Jan 20251049.95
10 Jan 20251061.9
09 Jan 20251103.55
08 Jan 20251102.1
07 Jan 20251092.8
06 Jan 20251092.2
03 Jan 20251105.75
02 Jan 20251114.4

Asset Value vs Market Value of Suven Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Pharmaceuticals Ltd

No data available

* All values are in crore

Suven Pharmaceuticals Ltd News Hub

News

Suven Pharmaceuticals schedules board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

28 Dec 2024 09:36

News

Suven Pharmaceuticals acquires 56% stake in NJ Bio Inc.

Suven Pharmaceuticals has acquired 56% equity share capital of NJ Bio, Inc. (target compan...

Read more

23 Dec 2024 11:34

News

Suven Pharmaceuticals strengths its ADC offering with acquisition of NJ Bio

Suven Pharmaceuticals announced the acquisition of a controlling stake in NJ Bio Inc. (NJ ...

Read more

07 Dec 2024 11:24

News

Suven Pharmaceuticals to acquire majority stake in US based NJ Bio

Suven Pharmaceuticals has executed definitive agreements today, i.e. 07 December 2024, for...

Read more

07 Dec 2024 11:20

News

Suven Pharma to acquire majority stake in US-based NJ Bio

The $64.4 million deal includes both primary equity infusion and secondary acquisition. As...

Read more

07 Dec 2024 17:20

News

Suven Pharmaceuticals Ltd Surges 4.23%

Suven Pharmaceuticals Ltd gained 4.23% today to trade at Rs 1359. The BSE Healthcare index...

Read more

02 Dec 2024 09:30

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Suven Pharmaceuticals Ltd

Why is it important to track the 52-week low of Suven Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Suven Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Suven Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Suven Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Suven Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Suven Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Suven Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Suven Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Suven Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Suven Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Suven Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Suven Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Suven Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions